Skip to main content

Advertisement

Log in

Use of Colonic Stents in Emergent Malignant Left Colonic Obstruction: A Markov Chain Monte Carlo Decision Analysis

  • Original COntributions
  • Published:
Diseases of the Colon & Rectum

Abstract

Purpose

This decision analysis examines the cost-effectiveness of colonic stenting as a bridge to surgery vs. surgery alone in the management of emergent, malignant left colonic obstruction.

Methods

We used a Markov chain Monte Carlo decision analysis model to determine the effect on health-related quality of life of two strategies: emergency surgery vs. emergency colonic stenting as a bridge to definitive surgery. All relevant health states were modeled during a patient’s expected lifespan. Outcome measures were mortality, the proportion of patients requiring a colostomy, quality-adjusted life expectancy, and costs. Deterministic and probabilistic sensitivity analyses were performed.

Results

In our model, colonic stenting was more effective (9.2 quality-adjusted life months benefit) and less costly (CAD $3,763; U.S. $3,135) than emergency surgery. Its benefits were secondary to reductions in acute mortality and in the likelihood of requiring a permanent colostomy. The results were only dependent on the rate of stenting complications (perforation, technical placement failure, and migration) and the patient’s risk of surgical mortality, with the benefits being greatest among patients at high risk of operative mortality.

Conclusions

Colonic stenting as a bridge to surgery is more effective and less costly than surgery in the treatment of emergent, malignant left colonic obstruction. The benefits are most pronounced in high-risk patients and are diminished by increases in stent placement failure rates and perforation rates. In low-risk patients, the benefits are more modest and may not outweigh the risks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2006. CA Cancer J Clin 2006;56:106-30.

    Article  PubMed  Google Scholar 

  2. Dauphine CE, Tan P, Beart RW, Vukasin P, Cohen H, Corman ML. Placement of self-expanding metal stents for acute malignant large-bowel obstruction: a collective review. Ann Surg Oncol 2002;9:574-.

    Article  PubMed  Google Scholar 

  3. Ness RM, Holmes AM, Klein R, Dittus R. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol 1999;94:1650-.

    Article  PubMed  CAS  Google Scholar 

  4. Ramsey SD, Andersen MR, Etzioni R, et al. Quality of life in survivors of colorectal carcinoma. Cancer 2000;88:1294-03.

    Article  PubMed  CAS  Google Scholar 

  5. Renner K, Rosen HR, Novi G, Holbling N, Schiessel R. Quality of life after surgery for rectal cancer: do we still need a permanent colostomy? Dis Colon Rectum 1999;42:1160-.

    Article  PubMed  CAS  Google Scholar 

  6. Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD. Quality of life in stoma patients. Dis Colon Rectum 1999;42:1569-4.

    Article  PubMed  CAS  Google Scholar 

  7. Park JJ, Del Pino A, Orsay CP, et al. Stoma complications: the Cook County Hospital experience. Dis Colon Rectum 1999;42:1575-0.

    Article  PubMed  CAS  Google Scholar 

  8. Gooszen AW, Geelkerken RH, Hermans J, Lagaay MB, Gooszen HG. Quality of life with a temporary stoma: ileostomy vs. colostomy. Dis Colon Rectum 2000;43:650-.

    Article  PubMed  CAS  Google Scholar 

  9. Sprangers MA, Taal BG, Aaronson NK, te Velde A. Quality of life in colorectal cancer: stoma vs. nonstoma patients. Dis Colon Rectum 1995;38:361-.

    Article  PubMed  CAS  Google Scholar 

  10. Dominitz JA, Provenzale D. Patient preferences and quality of life associated with colorectal cancer screening. Am J Gastroenterol 1997;97:2171-.

    Google Scholar 

  11. Tekkis PP, Kinsman R, Thompson MR, Stamatakis JD. The Association of Coloproctology of Great Britain and Ireland study of large bowel obstruction caused by colorectal cancer. Ann Surg 2004;240:76–81.

    Article  PubMed  Google Scholar 

  12. Martinez-Santos C, Lobato RF, Fradejas JM, Pinto I, Ortega Deballon P, Moreno Azcoita M. Self-expandable stent before elective surgery vs. emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary anastomosis and morbidity rates. Dis Colon Rectum 2002;45:401-.

    Article  PubMed  Google Scholar 

  13. Chen H-S, Sheen-Chen S-M. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends. Surgery 2000;127:370-.

    Article  PubMed  CAS  Google Scholar 

  14. Kelley WE Jr, Brown PW, Lawrence W Jr, Terz JJ. Penetrating, obstructing and perforating carcinomas of the colon and rectum. Arch Surg 1981;116:381-.

    PubMed  Google Scholar 

  15. Leitman IM, Sullivan JD, Brams D, DeCosse JJ. Multivariate analysis of morbidity and mortality from the initial surgical management of obstructing carcinoma of the colon. Surg Gynecol Obstet 1992;174:513-.

    PubMed  CAS  Google Scholar 

  16. Mulcahy HE, Skelly MM, Husain A, O’Donoghue DP. Long-term outcome following curative surgery for malignant large bowel obstruction. Br J Surg 1996;83:46–50.

    Article  PubMed  CAS  Google Scholar 

  17. Smothers L, Hynan L, Fleming J, Turnage R, Simmang C, Anthony T. Emergency surgery for colon carcinoma. Dis Colon Rectum 2003;46:24–30.

    Article  PubMed  Google Scholar 

  18. Al-Homoud S, Purkayastha S, Aziz O, et al. Evaluating operative risk in colorectal cancer surgery: ASA and POSSUM-based predictive models. Surg Oncol 2004;13:83–92.

    Article  PubMed  Google Scholar 

  19. Poon JT, Chan B, Law WL. Evaluation of P-POSSUM in surgery for obstructing colorectal cancer and correlation of the predicted mortality with different surgical options. Dis Colon Rectum 2005;48:493-.

    Article  PubMed  Google Scholar 

  20. Biondo S, Pares D, Frago R, et al. Large bowel obstruction: predictive factors for postoperative mortality. Dis Colon Rectum 2004;47:1889-7.

    Article  PubMed  Google Scholar 

  21. Sebastian S, Johnston S, Geoghegan T, Torreggiani W, Buckley M. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004;99:2051-.

    Article  PubMed  Google Scholar 

  22. Law WL, Choi HK, Lee YM, Chu KW. Palliation for advanced malignant colorectal obstruction by self-expanding metallic stents: prospective evaluation of outcomes. Dis Colon Rectum 2004;47:39–43.

    Article  PubMed  Google Scholar 

  23. Meisner S, Hensler M, Knop FK, West F, Wille-Jorgensen P. Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center. Dis Colon Rectum 2004;47:444-0.

    Article  PubMed  Google Scholar 

  24. Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T, et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost-effectiveness analysis. Surg Endosc 2004;18:421-.

    Article  PubMed  CAS  Google Scholar 

  25. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut AI. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003;95:230-.

    Article  PubMed  Google Scholar 

  26. McArdle CS, McMillan DC, Hole DJ. The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer. Br J Surg 2006;93:483-.

    Article  PubMed  CAS  Google Scholar 

  27. Porter GA, O’Keefe GE, Yakimets WW. Inadvertent perforation of the rectum during abdominoperineal resection. Am J Surg 1996;172:324-.

    Article  PubMed  CAS  Google Scholar 

  28. Slanetz CA Jr. The effect of inadvertent intraoperative perforation on survival and recurrence in colorectal cancer. Dis Colon Rectum 1984;27:792-.

    Article  PubMed  Google Scholar 

  29. Birkmeyer JD, Birkmeyer NO. Decision analysis in surgery. Surgery 1996;120:7–15.

    Article  PubMed  CAS  Google Scholar 

  30. Rabeneck L, Paszat LF, Rothwell DM, He J. Temporal trends in new diagnoses of colorectal cancer with obstruction, perforation, or emergency admission in Ontario: 1993-001. Am J Gastroenterol 2005;100:672-.

    Article  PubMed  Google Scholar 

  31. Ng KC, Law WL, Lee YM, Choi HK, Seto CL, Ho JW. Self-expanding metallic stent as a bridge to surgery versus emergency resection for obstructing left-sided colorectal cancer: a case-matched study. J Gastrointest Surg 2006;10:798–803.

    Article  PubMed  Google Scholar 

  32. Saida Y, Sumiyama Y, Nagao J, Uramatsu M. Long-term prognosis of preoperative “bridge to surgery-expandable metallic stent insertion for obstructive colorectal cancer: comparison with emergency operation. Dis Colon Rectum 2003;46(Suppl):S44-.

    PubMed  Google Scholar 

  33. Rudinskaite G, Tamelis A, Saladzinskas Z, Pavalkis D. Risk factors for clinical anastomotic leakage following the resection of sigmoid and rectal cancer. Medicina (Kaunas) 2005;41:741-.

    Google Scholar 

  34. Bowne WB, Lee B, Wong WD, et al. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum 2005;48:897–909.

    Article  PubMed  Google Scholar 

  35. Koruth NM, Krukowski ZH, Youngson GG, et al. Intra-operative colonic irrigation in the management of left-sided large bowel emergencies. Br J Surg 1985;72:708-1.

    Article  PubMed  CAS  Google Scholar 

  36. Tan SG, Nambiar R, Rauff A, Ngoi SS, Goh HS. Primary resection and anastomosis in obstructed descending colon due to cancer. Arch Surg 1991;126:748-1.

    PubMed  CAS  Google Scholar 

  37. Biondo S, Pares D, Kreisler E, et al. Anastomotic dehiscence after resection and primary anastomosis in left-sided colonic emergencies. Dis Colon Rectum 2005;48:2272-0.

    Article  PubMed  Google Scholar 

  38. Branagan G, Finnis D. Prognosis after anastomotic leakage in colorectal surgery. Dis Colon Rectum 2005;48:1021-.

    Article  PubMed  Google Scholar 

  39. Walker KG, Bell SW, Rickard MJ, et al. Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg 2004;240:255-.

    Article  PubMed  Google Scholar 

  40. Patriti A, Contine A, Carbone E, Gulla N, Donini A. One-stage resection without colonic lavage in emergency surgery of the left colon. Colorectal Dis 2005;7:332-.

    Article  PubMed  CAS  Google Scholar 

  41. Konishi T, Watanabe T, Kishimoto J, Nagawa H. Risk factors for anastomotic leakage after surgery for colorectal cancer: results of prospective surveillance. J Am Coll Surg 2006;202:439-4.

    Article  PubMed  Google Scholar 

  42. Tang R, Chen HH, Wang YL, et al. Risk factors for surgical site infection after elective resection of the colon and rectum: a single-centre prospective study of 2809 consecutive patients. Ann Surg 2001;234:181-.

    Article  PubMed  CAS  Google Scholar 

  43. Pokorny H, Herkner H, Jakesz R, Herbst F. Mortality and complications after stoma closure. Arch Surg 2005;140:956-0.

    Article  PubMed  Google Scholar 

  44. Sutton CD, Marshall LJ, Williams N, Berry DP, Thomas WM, Kelly MJ. Colorectal anastomotic leakage often masquerades as a cardiac complication. Colorectal Dis 2003;6:21-.

    Article  Google Scholar 

  45. Maggard MA, Zingmond D, O’Connell JB, Ko CY. What proportion of patients with an ostomy (for diverticulitis) get reversed? Am Surg 2004;70:928-1.

    PubMed  Google Scholar 

  46. Dixon AR, Holmes JT. Hartmann’s procedure for carcinoma of rectum and distal sigmoid colon: 5-year audit. J R Coll Surg Edinb 1990;35:166-.

    PubMed  CAS  Google Scholar 

  47. Desai DC, Brennan EJ, Reilly JF, Smink RD. The utility of the Hartmann procedure. Am J Surg 1998;175:152-.

    Article  PubMed  CAS  Google Scholar 

  48. Keck JO, Collopy BT, Ryan PJ, Fink R, Mackay JR, Woods RJ. Reversal of Hartmann’s procedure: effect of timing and technique on ease and safety. Dis Colon Rectum 1994;37:243-.

    Article  PubMed  CAS  Google Scholar 

  49. Banerjee S, Leather AJ, Rennie JA, Samano N, Gonzalez JG, Papagrigoriadis S. Feasibility and morbidity of reversal of Hartmann’s. Colorectal Dis 2005;7:454-.

    Article  PubMed  CAS  Google Scholar 

  50. Tepper JE, O’Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. J Clin Oncol 2003;21:3623-.

    Article  PubMed  CAS  Google Scholar 

  51. Goldberg RM, Fleming TR, Tangen CM, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Ann Intern Med 1998;129:27–35.

    PubMed  CAS  Google Scholar 

  52. Freund HR, Raniel J, Sulam MM. Factors affecting the morbidity of colostomy closure: a retrospective study. Dis Colon Rectum 1982;25:712-.

    Article  PubMed  CAS  Google Scholar 

  53. Gamjobst W, Leaverton GH, Sullivan ES. Safety of colostomy closure. Am J Surg 1978;136:85-.

    Article  Google Scholar 

  54. Knox AJ, Birkett FD, Collins CD. Closure of colostomy. Br J Surg 1971;58:669-2.

    Article  PubMed  CAS  Google Scholar 

  55. Parks SE, Hastings PR. Complications of colostomy closure. Am J Surg 1985;149:672-.

    Article  PubMed  CAS  Google Scholar 

  56. Pittman DM, Smith LE. Complications of colostomy closure. Dis Colon Rectum 1985;28:836-3.

    Article  PubMed  CAS  Google Scholar 

  57. Riesener KP, Lehnen W, Hofer M, Kasperk R, Braun JC, Schumpelick V. Morbidity of ileostomy and colostomy closure: impact of surgical technique and perioperative treatment. World J Surg 1997;21:103-.

    Article  PubMed  CAS  Google Scholar 

  58. Rosen L, Friedman IH. Morbidity and mortality following intra–peritoneal closure of transverse loop colostomy. Dis Colon Rectum 1980;23:508-2.

    Article  PubMed  CAS  Google Scholar 

  59. Salley RK, Bucher RM, Rodning CB. Colostomy closure: morbidity reduction employing a semi–standardized protocol. Dis Colon Rectum 1983;26:319-2.

    Article  PubMed  CAS  Google Scholar 

  60. Read TE, Mutch MG, Chang BW, et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 2002;195:33–40.

    Article  PubMed  Google Scholar 

  61. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-8.

    Article  PubMed  CAS  Google Scholar 

  62. Verdecchia A, De Angelis R, Capocaccia R, et al. The cure for colon cancer: results from the EUROCARE study. Int J Cancer 1998;77:322-.

    Article  PubMed  CAS  Google Scholar 

  63. Lee ET, Go OT. Survival analysis in public health research. Annu Rev Public Health 1997;18:105-4.

    Article  PubMed  CAS  Google Scholar 

  64. Surveillance, Epidemiology and End Results (SEER) program Public-Use Data (1973-002). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission. Available at: http://www.seer.cancer.gov. Accessed May 2006.

  65. Miller AR, Cantor SB, Peoples GE, Pearlstone DB, Skibber JM. Quality of life and cost-effectiveness analysis of therapy for locally recurrent rectal cancer. Dis Colon Rectum 2000;43:1695-01.

    Article  PubMed  CAS  Google Scholar 

  66. Taylor WE, Donohue JH, Gunderson LL, et al. The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann Surg Oncol 2002;9:177-5.

    Article  PubMed  Google Scholar 

  67. Schedule of benefits: Physician Services. Available at: http://www.health.gov.on.ca/english/providers/program/ohip/sob/physserv/physserv_mn.html. Accessed June 26, 2006.

  68. Maroun J, Ng E, Berthelot J-M, et al. Lifetime costs of colon and rectal cancer management in Canada. Chronic Dis Can 2003;24:91–101.

    PubMed  Google Scholar 

  69. Ontario Case Costing Project. Available at: http://www.occp.ocm. Accessed November 2005.

  70. Guidelines for the economic evaluation of health technologies: Canada (3rd edition): Ottawa:Canadian Agency for Drugs and Technologies in Health; 2006 (Available at: http://www.cadth.ca/media/pdf/186_EconomicGuidelines_e.pdf).

  71. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.

    Google Scholar 

  72. Claxton K, Sculpher M, McCabe C, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005;14:339-7.

    Article  PubMed  Google Scholar 

  73. Ades AE, Claxton K, Sculpher M. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. Health Econ 2006;15:373-1.

    Article  PubMed  CAS  Google Scholar 

  74. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146:473-1.

    PubMed  CAS  Google Scholar 

  75. Richardson WS, Detsky AS. Users-Guides to the Medical Literature: VII. How to use a clinical decision analysis: B. What are the results and will they help me in caring for my patients? JAMA 1995;273:1610-.

    Article  PubMed  CAS  Google Scholar 

  76. Wright JC, Weinstein MC. Gains in life expectancy from medical interventions - standardizing data on outcomes. N Engl J Med 1998;339:380-.

    Article  PubMed  CAS  Google Scholar 

  77. Targownik LE, Spiegel BM, Sack J, et al. Colonic stent vs. emergency surgery for management of acute left-sided malignant colonic obstruction: a decision analysis. Gastrointest Endosc 2004;60:865-4.

    Article  PubMed  Google Scholar 

  78. Osman HS, Rashid HI, Sathananthan N, Parker MC. The cost-effectiveness of self expanding metal stents in the management of malignant left-sided large bowel obstruction. Colorectal Dis 2000;2:233-.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Calvin H. L. Law M.D., M.P.H..

Additional information

Dr. Govindarajan receives salary support from the National Cancer Institute of Canada Clinical Research Fellowship. Dr. Law receives salary support as a Career Scientist from the Ontario Ministry of Health and Long-term Care. Neither of these organizations was involved in any aspect of this study.

Read at the meeting of The American Society of Colon and Rectal Surgeons, Seattle, Washington, June 3 to 7, 2006.

About this article

Cite this article

Govindarajan, A., Naimark, D., Coburn, N.G. et al. Use of Colonic Stents in Emergent Malignant Left Colonic Obstruction: A Markov Chain Monte Carlo Decision Analysis. Dis Colon Rectum 50, 1811–1824 (2007). https://doi.org/10.1007/s10350-007-9047-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-007-9047-9

Key words

Navigation